SCHEMBL883869

SCHEMBL883869

CC1[C]=NNC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5362264 0.65
SCHEMBL11973662 0.60
SCHEMBL1553497 0.59
SCHEMBL2273694 0.59
SCHEMBL12160740 0.57
SCHEMBL357257 0.57
SCHEMBL13721426 0.57
SCHEMBL122515 0.57
SCHEMBL20614486 0.55 CREBBP (0.52)
SCHEMBL1372797 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1553096-B1 PYRAZOLE COMPOUNDS UBE INDUSTRIES (JP) 2012-10-31 EP claimed
EP-1459742-B9 Agent for prophylaxis and treatment of asthenopia and pseudomyopia SENJU PHARMA CO (JP) 2012-05-02 EP claimed
EP-1459742-B1 Agent for prophylaxis and treatment of asthenopia and pseudomyopia SENJU PHARMA CO (JP) 2011-10-12 EP claimed
EP-1295607-B9 ANTITUMOR EFFECT POTENTIATORS MITSUBISHI TANABE PHARMA CORP (JP) 2011-10-05 EP claimed
US-7956072-B2 Agent for repairing corneal sensitivity containing amide compound SENJU PHARMACEUTICAL CO., LTD. (JP) 2011-06-07 US claimed
EP-1177796-B1 Medicament for prevention or therapeutic treatment of liver disease MITSUBISHI TANABE PHARMA CORP (JP) 2011-04-27 EP claimed
EP-0956865-B2 MEDICINES COMPRISING Rho KINASE INHIBITOR MITSUBISHI TANABE PHARMA CORP (JP) 2010-08-18 EP claimed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP claimed
EP-1295607-B1 ANTITUMOR EFFECT POTENTIATORS MITSUBISHI TANABE PHARMA CORP (JP) 2010-04-28 EP claimed
US-20090247552-A1 AQUEOUS LIQUID PREPARATION CONTAINING AMIDE COMPOUND SENJU PHARMACEUTICAL CO., LTD. (JP) 2009-10-01 US claimed
EP-1163910-A1 PREVENTIVES/REMEDIES FOR INTERSTITIAL PNEUMONIA AND PULMONARY FIBROSIS Welfide Corporation (JP) 2001-12-19 EP claimed
EP-1034793-A1 PREVENTIVES/REMEDIES FOR GLAUCOMA Senju Pharmaceutical Co., Ltd. (JP) 2000-09-13 EP claimed
EP-0956865-A1 MEDICINES COMPRISING Rho KINASE INHIBITOR YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-11-17 EP claimed
WO-1999031071-A1 NEW PHTHALAZINONES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1999-06-24 WO claimed
EP-0280224-B1 Substituted 3H-indoles, process for their preparation and medicines containing them BOEHRINGER MANNHEIM GMBH (DE) 1994-06-01 EP claimed
EP-0223937-B1 INDOLES SUBSTITUTED WITH HETEROCYCLES, INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS Roche Diagnostics GmbH (DE) 1992-03-18 EP claimed
US-4925845-A HYPOTENSIVE AGENTS BOEHRINGER MANNHEIM GMBH (DE) 1990-05-15 US claimed
US-4851406-A CARDIOVASCULAR DISORDERS, HYPOTENSIVE BOEHRINGER MANNHEIM GMBH (DE) 1989-07-25 US claimed
EP-0240026-A1 Heterocyclically substituted benzimidazoles, method for their preparation and medicines containing these compounds Roche Diagnostics GmbH (DE) 1987-10-07 EP claimed
EP-0223937-A1 Indoles substituted with heterocycles, intermediates, process for their preparation and medicaments Roche Diagnostics GmbH (DE) 1987-06-03 EP claimed